Dr. Levi Garraway is Senior Vice President of Global Oncology at Eli Lilly and Company.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical trials after the 2021 CRI Virtual Immunotherapy Patient Summit.
Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit.